Francesco Cortiula
Udine, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Assessing the impact of proton versus photon therapy on health-related quality of life in lung cancer.
Journal: Clinical and translational radiation oncology
Published: January 27, 2026
Node-RADS v1.0 on chest CT for lung cancer: Reproducibility and diagnostic performance.
Journal: European journal of radiology
Published: October 31, 2025
Pretreatment Risk Model for Radiation-Induced Lymphopenia Is Associated With Adjuvant Durvalumab Efficacy in Patients With Unresectable Stage III NSCLC.
Journal: International journal of radiation oncology, biology, physics
Published: October 20, 2025
Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 05, 2025
De-escalation strategies with targeted therapies in non-small cell lung cancer.
Journal: Cancer treatment reviews
Published: June 01, 2025
The prognostic and predictive value of peripheral immune-related proteins in patients with lung cancer treated with radiotherapy.
Journal: Frontiers in oncology
Published: May 08, 2025
Updated treatment recommendations for systemic treatment: from the ESMO oncogene-addicted metastatic NSCLC living guideline.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 15, 2025
Updated treatment recommendations for systemic treatment: from the ESMO non-oncogene-addicted metastatic NSCLC Living Guideline.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 11, 2025
Chemoradiotherapy efficacy in patients with stage III non-small cell lung cancer (NSCLC): A prognostic clinical and biomarker-based model.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 21, 2025
De-Escalation Strategies With Immune Checkpoint Blockers in Non-Small Cell Lung Cancer: Do We Already Have Enough Evidence?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 21, 2025
Oligometastatic NSCLC: Current Perspectives and Future Challenges.
Journal: Current oncology (Toronto, Ont.)
Published: December 03, 2024
Comparative efficacy of immunotherapy-based treatment versus chemotherapy-only in patients with unresectable NSCLC with disease progression post chemoradiation and durvalumab.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 22, 2024
Last Updated: 09/26/2026